Breaking News Instant updates and real-time market news.

ACB

Aurora Cannabis

$3.59

0.02 (0.56%)

16:10
11/04/19
11/04
16:10
11/04/19
16:10

Aurora Cannabis initiated with a Neutral at Cantor Fitzgerald

Cantor Fitzgerald analyst Pablo Zuanic initiated coverage of Aurora Cannabis with a Neutral rating and C$5.10 price target.

  • 12

    Nov

ACB Aurora Cannabis
$3.59

0.02 (0.56%)

10/14/19
MKMP
10/14/19
NO CHANGE
MKMP
Sell
Aurora Cannabis price target lowered to CAD3.50 from CAD5 at MKM Partners
MKM Partners analyst Bill Kirk lowered his price target on Aurora Cannabis to CAD3.50 and kept his Sell rating ahead of its Q1 earnings later this month. The analyst notes that the "absolute industry pricing" has softened and the company's new store openings in Ontario and Quebec are trending below expectations. Kirk contends that the sequential net sales growth assumed in Aurora Cannabis Q3 expectations is "unlikely".
10/16/19
BOFA
10/16/19
NO CHANGE
BOFA
BofA lowers cannabis stock price targets on further sales estimate changes
Following yesterday's rally in cannabis stock's driven by Aphria's (APHA) earnings, BofA Merrill Lynch analyst Christopher Carey said he doesn't see a case for sustainable upside yet until consensus estimates are cut further, which he thinks will ensue with the calendar Q3 results from the group. The reason that industry sales could be flat to down quarter-over-quarter sector-wide is that the cannabis industry is going from a period of inventory build to one of inventory "de-load," said Carey. Given his sales estimate revisions, he has lowered his price target on Aurora Cannabis (ACB) shares to $5 from $6, cut his Canopy Growth (CGC) price target to $23 from $27, trimmed his Cronos Group (CRON) target to $13 from $16 and decreased his Hexo (HEXO) target to $2 from $2.50. Carey keeps a Buy rating on Cronos, has Neutral ratings on Aurora and Canopy and maintains an Underperform rating on Hexo.
10/22/19
PIPR
10/22/19
NO CHANGE
Target $12
PIPR
Overweight
Piper cuts targets in Cannabis, says Canopy and Cronos best positioned
Piper Jaffray analyst Michael Lavery revisited the four Canadian licensed producers under his coverage, namely Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON) and Tilray (TLRY). The analyst continues to believe Canopy and Cronos look best positioned. Both companies have strong cash positions to facilitate growth and have good visibility on key strategic priorities, Lavery tells investors in a research note. The analyst cut his estimates for Tilray, but he keeps an Overweight rating on the shares as he still sees growth potential in both Europe and the U.S. Lavery believes Aurora lacks visibility on key strategic growth priorities and he keeps a Neutral rating on the shares. The analyst lowered his price target for Aurora to $4 from $7, for Canopy to $36 from $40, for Cronos to $12 from $18, and for Tilray to $31 from $72.
10/31/19
LTCO
10/31/19
NO CHANGE
Target $29
LTCO
Buy
Cannabis sector investor sentiment is now 'very low,' says Ladenburg
After a long period of negative news flow and stock performance, sentiment in the cannabis sector is "very low," Ladenburg Thalmann analyst Glenn Mattson tells investors in a research note. After participating in a number of cannabis conferences, the analyst believes the biggest contributor to the negative backdrop has been the flat lining of growth in Canada. This is mainly a result of a poor retail footprint, only 25 stores in the nation's largest province, Ontario for instance, versus more than 300 in Alberta, according to Mattson. Adding to this negative backdrop are expectations that acquisitions done at much higher levels will lead to goodwill write-downs, adds the analyst. However, he points out that goodwill write-downs are not always viewed as a negative from a stock performance perspective. While the news flow continues to be negative, a resumption of better growth as reported by the Canadian government "holds some promise while we await Cannabis 2.0," says the analyst. 2.0 refers to the second wave of cannabis derivative products, such as edibles and beverages, that will begin to be available in Canada in December. Mattson lowered his price target for Canopy Growth (CGC) to $29 from $42, for Acreage Holdings (ACRGF) to $16 from $18, and for Aurora Cannabis (ACB) to $6 from $9. He keeps Buy ratings on all three stocks, however.

TODAY'S FREE FLY STORIES

MGNX

MacroGenics

$9.59

0.27 (2.90%)

10:07
12/11/19
12/11
10:07
12/11/19
10:07
Hot Stocks
Breaking Hot Stocks news story on MacroGenics »

MacroGenics halted for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BY

Byline Bancorp

$18.21

(0.00%)

10:07
12/11/19
12/11
10:07
12/11/19
10:07
Conference/Events
Byline Bancorp management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 18

    Dec

BY

Byline Bancorp

$18.21

(0.00%)

10:06
12/11/19
12/11
10:06
12/11/19
10:06
Conference/Events
Byline Bancorp management to meet with Stephens »

Group Luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 18

    Dec

MGNX

MacroGenics

$9.60

0.28 (3.00%)

10:06
12/11/19
12/11
10:06
12/11/19
10:06
Hot Stocks
Breaking Hot Stocks news story on MacroGenics »

MacroGenics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KZIA

Kazia Therapeutics

$4.60

0.35 (8.24%)

10:06
12/11/19
12/11
10:06
12/11/19
10:06
Hot Stocks
Kazia Therapeutics says lead program selected for glioblastoma study »

Kazia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$227.16

2.11 (0.94%)

10:05
12/11/19
12/11
10:05
12/11/19
10:05
Options
Palo Alto Networks call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

MGNX

MacroGenics

$9.50

0.18 (1.93%)

10:04
12/11/19
12/11
10:04
12/11/19
10:04
Hot Stocks
MacroGenics: Margetuximab didn't reach statistical significance in analysis »

MacroGenics presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$145.50

-1.71 (-1.16%)

, GOOG

Alphabet

$1,345.53

1.03 (0.08%)

10:02
12/11/19
12/11
10:02
12/11/19
10:02
Periodicals
Roku faces competition after building dominant streaming box, Bloomberg reports »

Roku (ROKU) has been…

ROKU

Roku

$145.50

-1.71 (-1.16%)

GOOG

Alphabet

$1,345.53

1.03 (0.08%)

GOOGL

Alphabet Class A

$1,343.75

0.71 (0.05%)

SSNLF

Samsung

$0.00

(0.00%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-0.3 (-0.70%)

T

AT&T

$38.09

0.02 (0.05%)

AAPL

Apple

$270.00

1.38 (0.51%)

AMZN

Amazon.com

$1,743.43

4.28 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 29

    Jan

MGNX

MacroGenics

$9.44

0.12 (1.29%)

10:01
12/11/19
12/11
10:01
12/11/19
10:01
Hot Stocks
Breaking Hot Stocks news story on MacroGenics »

MacroGenics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AME

Ametek

$98.43

0.36 (0.37%)

09:59
12/11/19
12/11
09:59
12/11/19
09:59
Conference/Events
Ametek management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SGEN

Seattle Genetics

$113.88

-0.09 (-0.08%)

09:58
12/11/19
12/11
09:58
12/11/19
09:58
Hot Stocks
Seattle Genetics says tucatinib shows statistical benefit in breast cancer study »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

AGIO

Agios Pharmaceuticals

$43.89

-0.37 (-0.84%)

09:56
12/11/19
12/11
09:56
12/11/19
09:56
Conference/Events
Agios Pharmaceuticals management to meet with Piper Jaffray »

Group Investor Luncheon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

PCG

PG&E

$12.99

0.66 (5.35%)

, FCX

Freeport McMoRan

$12.64

0.355 (2.89%)

09:55
12/11/19
12/11
09:55
12/11/19
09:55
Options
Early notable gainers among liquid option names on December 11th »

Notable gainers among…

PCG

PG&E

$12.99

0.66 (5.35%)

FCX

Freeport McMoRan

$12.64

0.355 (2.89%)

BEN

Franklin Resources

$26.03

0.195 (0.75%)

FLR

Fluor

$16.73

0.39 (2.39%)

WDC

Western Digital

$50.65

1.4 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

CGC

Canopy Growth

$20.66

0.57 (2.84%)

09:55
12/11/19
12/11
09:55
12/11/19
09:55
Conference/Events
Canopy Growth management to meet with Cantor Fitzgerald »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

XLNX

Xilinx

$91.94

0.69 (0.76%)

09:53
12/11/19
12/11
09:53
12/11/19
09:53
Conference/Events
Xilinx participates in a conference call with Benchmark »

Semiconductor Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 28

    Jan

GOOG

Alphabet

$1,347.30

2.8 (0.21%)

, GOOGL

Alphabet Class A

$1,345.00

1.96 (0.15%)

09:48
12/11/19
12/11
09:48
12/11/19
09:48
Hot Stocks
YouTube bans malicious insults based on race, sexual orientation »

In an update to its…

GOOG

Alphabet

$1,347.30

2.8 (0.21%)

GOOGL

Alphabet Class A

$1,345.00

1.96 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$31.71

-0.24 (-0.75%)

09:48
12/11/19
12/11
09:48
12/11/19
09:48
Hot Stocks
FDA posts briefing documents for panel meeting to review Horizon Pharma BLA »

The FDA has posted to its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

GMRE

Global Medical REIT

$13.02

-1.065 (-7.56%)

09:47
12/11/19
12/11
09:47
12/11/19
09:47
Hot Stocks
Global Medical REIT falls -8.0% »

Global Medical REIT is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

UNFI

United Natural Foods

$8.62

-1.26 (-12.75%)

09:47
12/11/19
12/11
09:47
12/11/19
09:47
Hot Stocks
United Natural Foods falls -13.0% »

United Natural Foods is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

GME

GameStop

$5.62

-0.88 (-13.54%)

09:47
12/11/19
12/11
09:47
12/11/19
09:47
Hot Stocks
GameStop falls -14.0% »

GameStop is down -14.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SBGL

Sibanye-Stillwater

$8.94

0.44 (5.18%)

09:47
12/11/19
12/11
09:47
12/11/19
09:47
Hot Stocks
Sibanye-Stillwater rises 5.3% »

Sibanye-Stillwater is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PACK

Ranpak Holdings

$5.95

(0.00%)

09:47
12/11/19
12/11
09:47
12/11/19
09:47
Hot Stocks
Ranpak Holdings rises 5.5% »

Ranpak Holdings is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CHH

Choice Hotels

$102.62

5.22 (5.36%)

09:47
12/11/19
12/11
09:47
12/11/19
09:47
Hot Stocks
Choice Hotels rises 5.4% »

Choice Hotels is up 5.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
12/11/19
12/11
09:45
12/11/19
09:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

AAPL

Apple

$268.62

(0.00%)

09:44
12/11/19
12/11
09:44
12/11/19
09:44
Recommendations
Apple analyst commentary  »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.